ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "T cells"

  • 2017 American Transplant Congress

    Distinctive Molecular Features of Antibody-Mediated versus T-Cell Mediated Rejection in Facial Transplantation.

    R. Lopdrup, T. Win, N. Murakami, J. Teague, A. Chandraker, G. Murphy, C. Lian, E. Bueno, B. Pomahac, R. Clark, L. Riella.

    Brigham and Women's Hospital, Boston, MA

    BackgroundA single case of antibody-mediated rejection in a clinical face transplant has been reported worldwide. The availability of repeated allograft biopsies from this patient allowed…
  • 2017 American Transplant Congress

    A Regulatory T Cell (Treg)-Intrinsic Role for p27kip1 in Acquired Transplant Tolerance.

    P. Morawski, L. Wang, X. Yang, Y. Chen, W. Hancock, A. Wells.

    Pathology, The Children's Hospital of Philadelphia, Philadelphia, PA

    We previously found that the cyclin-dependent kinase CDK2 phosphorylates the Treg transcription factor Foxp3, targeting it for proteolytic degradation. Treg with defective CDK2 activity express…
  • 2017 American Transplant Congress

    Identification of Kidney Transplant Patients at Risk for Skin Cancer by Differentially Methylated Regions in T Cells.

    F. Peters,1 A. Peeters,1 P. Mandaviya,2 J. van de Wetering,1 M. Betjes,1 C. Baan,1 K. Boer.1

    1Nephrology and Transplantation, Erasmus MC, University Medical Center, Rotterdam, Netherlands; 2Clinical Chemistry, Erasmus MC, University Medical Center, Rotterdam, Netherlands

    Skin cancer, specifically cutaneous squamous cell carcinoma (cSCC), is the most often occurring malignancy in patients after organ transplantation, with an incidence of 100-200 times…
  • 2017 American Transplant Congress

    Contribution of Donor versus Recipient T Cells in Face Transplant Rejection.

    T. Win,1 N. Murakami,2 I. Avraham-Davidi,1 J. Teague,1 E. Lowry,1 R. Lopdrup,1 E. Bueno,1 A. Chandraker,1 L. Riella,1 B. Pomahac,1 R. Clark.1

    1Brigham and Women's Hospital, Boston; 2Broad Institute of MIT and Harvard, Cambridge

    BackgroundSkin-containing transplants such as facial allografts contain resident populations of donor T cells. Although the role of T cells in acute rejection is well established,…
  • 2017 American Transplant Congress

    Novel Cell Intrinsic Role of the Adaptor Protein TSAd in Maintaining Alloimmune T Regulatory Cell Function.

    J. Wedel,1,2 M. Stack,1,2 T. Seto,1,2 M. Sheehan,1,2 K. Liu,1,2 E. Flynn,1,2 D. Briscoe.1,2

    1Transplant Research Program, Boston Children's Hospital, Boston; 2Department of Pediatrics, Harvard Medical School, Boston

    TSAd is an SH2 domain containing intracellular adapter molecule that functions to elicit T cell receptor-mediated signals and cytokine production. TSAd knockout (KO) T cells…
  • 2017 American Transplant Congress

    Medicinal Herb Cordyceps Sinensis Promotes Long-Term Allograft Survival by Tipping the Balance Between CD4+FoxP3+ Tregs and CD8+ Tcm Cells.

    Z. Dai,1 H. Dai.2

    1Guangdong Provincial Academy of Chinese Medical Sciences, Guangzhou, China; 2University of Pittsburgh, Pittsburgh, PA

    Achieving long-term allograft survival or tolerance without continuously global immunosuppression is highly desirable in transplantation. This study was set to induce long-term allograft survival using…
  • 2017 American Transplant Congress

    Operational Tolerance in Intestinal Transplantation: A Proven Possibility.

    B. Houlihan,1 P. Cha,1,2 C. Cosentino,1,2 J. Kaiser,1,2 A. Shukla,1 J. Hawksworth,1,2 C. Matsumoto,1 T. Fishbein,1 A. Kroemer.1

    1Transplant Department, Medstar Georgetown University Hospital, Washington, DC; 2Surgery, Walter Reed National Military Medical Center, Bethesda, MD

    A The purpose of this study is to immunologically characterize the first operationally tolerant intestinal transplant (ITx) patient known to date.B Flow cytometry and rtPCR…
  • 2017 American Transplant Congress

    B Cell-Derived Cytokines Rather Than T/B Cognate Interactions Mediate CD8 T Cell Reconstitution Following Lymphoablation.

    D. Zwick, K. Ayasoufi, R. Fan, V. Gorbacheva, K. Keslar, R. Fairchild, A. Valujskikh.

    Immunology, Cleveland Clinic, Cleveland, OH

    Antibody-mediated lymphoablation is a commonly used induction therapy in sensitized transplant recipients. Using murine anti-thymocyte globulin (mATG) in a model of BALB/c (H-2d) to B6…
  • 2017 American Transplant Congress

    Maximizing the Potential of Treg-Based Therapies for Transplant Rejection via Computational Immune-Modeling: Effect of Dose, Timing, and Distribution.

    G. Raimondi,1 A. Arun,1 O. Dorabiala,2 J. Arciero.3

    1Plastic & Reconstructive Surgery, Johns Hopkins University, Baltimore; 2Mathematics, Pennsylvania State University, Philadelphia; 3Mathematical Sciences, Indiana University-Purdue University Indianapolis, Indianapolis

    Purpose. Regulatory T cells (Treg), endogenous regulators of the immune system, have a significant therapeutic potential for prevention of transplant rejection. Experimental evidences however, indicate…
  • 2017 American Transplant Congress

    Evaluating T Cell Repopulation Post Alemtuzumab Induction with a Belatacept-Based Regimen.

    V. Bendersky, H. Xu, A. Kirk.

    Department of Surgery, Duke University, Durham, NC

    We reported that alemtuzumab induction followed by belatacept-sirolimus based immunosuppression effectively prevents costimulation blockade resistant rejection (CoBRR). This study investigates the phenotypic characteristics of repopulating…
  • « Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 53
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences